Medical bill for rheumatic arthritis patients will go down

The cost that individuals will have to shoulder for treatment of advanced or progressive rheumatic arthritis will go down from this month will go down thanks to the government’s plan to restructure the national health insurance scheme, according to Schering Korea.

Under the plan, those receiving Remicade (infliximab) will be reimbursable without restriction of treatment period of advanced or...